Search For "drug controller general of india"
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 2 years, 1 month ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More
COVID-19: AIIMS Bhopal conducting multicentric study on Mycobacterium w
Updated : 2 years, 1 month ago IST
Bhopal (Madhya Pradesh) [India], April 30 (ANI): A multicentric study on the use Mycobacterium w (Mw), heat-killed Mycobacterium indicus pranii, as an adjunct to the treatment of coronavirus is being conducted at AIIMS Bhopal with the approval of Drug Controller General of India.
Read More
Glenmark to conduct clinical trials on Favipiravir anti-viral tablets for
Updated : 2 years, 1 month ago IST
Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir anti-viral tablets on COVID-19 patients.
Read More
DCGI permits import of drug with residual shelf life less than 60 pc
Updated : 2 years, 2 months ago IST
New Delhi [India], April 18 (ANI): In view of the COVID-19 pandemic, the country's top drug controller has granted permission for the import of drugs with residual shelf life less than 60 per cent under special conditions. This will be effective for a period of three months or till further o
Read More
DGCI gives test license to 18 companies to conduct COVID-19 tests
Updated : 2 years, 3 months ago IST
New Delhi [India], Mar 20 (ANI): The Drug Controller General of India (DCGI) has given test licence to 18 companies including international and private companies to conduct coronavirus (COVID-19) tests in India.
Read More
Zydus announces world's first drug for treatment of NASH
Updated : 2 years, 3 months ago IST
Ahmedabad (Gujarat) [India], Mar 5 (ANI): Global pharmaceutical company Zydus Cadila, on Thursday announced that the Drug Controller General of India (DCGI) has approved its new drug application (NDA) for Saroglitazar, a medicine for the treatment of a liver disease called Non-Cirrhotic Non-
Read More
